Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

HEPAHEPA
2 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in Hepion Pharmaceuticals, Inc.

CITADEL ADVISORS LLC previously held 0 shares of HEPA (Hepion Pharmaceuticals, Inc.), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$6,698

Total Shares Change

-15,581

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$0.07
0
2025-Q1
New
15,581
-
$6,6980.0%$0.48
24

Other major holders of HEPA: HRT FINANCIAL LP, XTX Topco Ltd, BlackRock, Inc., PNC FINANCIAL SERVICES GROUP, INC., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used